EYE TECH CARE announces closing of a 25 million funding and partnership agreement with EVERPINE Capital

LYON, France--(BUSINESS WIRE)--EYE TECH CARE SA, a French company developing and marketing equipment for non-invasive glaucoma treatment in ophthalmology, today announced that it has secured a new round of funding with a Chinese investor. EVERPINE Capital will invest in two rounds for a total amount of around 25 million euros and will support EYE TECH CARE in its international expansion. The company will benefit from EVERPINE Capital’s presence in China in order to further continue product regi

Full Story →